Portal de Periódicos da CAPES

Revisão Acesso aberto Produção Nacional Revisado por pares

BIBTEX RIS

The A–Z of Zika drug discovery

2018; Elsevier BV; Volume: 23; Issue: 11 Linguagem: Inglês

10.1016/j.drudis.2018.06.014

1878-5832

Melina Mottin, Joyce V. V. B. Borba, Rodolpho C. Braga, Pedro Henrique Monteiro Torres, Matheus Cavalheiro Martini, José Luiz Proença‐Módena, Carla C. Judice, Fábio Trindade Maranhão Costa, Sean Ekins, Alexander L. Perryman, Carolina Horta Andrade,

Malaria Research and Control

Despite the recent outbreak of Zika virus (ZIKV), there are still no approved treatments, and early-stage compounds are probably many years away from approval. A comprehensive A–Z review of the recent advances in ZIKV drug discovery efforts is presented, highlighting drug repositioning and computationally guided compounds, including discovered viral and host cell inhibitors. Promising ZIKV molecular targets are also described and discussed, as well as targets belonging to the host cell, as new opportunities for ZIKV drug discovery. All this knowledge is not only crucial to advancing the fight against the Zika virus and other flaviviruses but also helps us prepare for the next emerging virus outbreak to which we will have to respond.